Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of long-acting Teverelix in advanced prostate cancer
2006-004264-31Phase 2Completed
- Sponsor
- Ardana
- Start
- Feb 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of teverelix in prostate cancer (PCa), sponsored by Ardana. Primary endpoint: Primary: Castration-level testosterone generation and maintenance. Started Feb 2007; status: completed.
02
Drugs
teverelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-004264-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004264-31.